United States · FDA National Drug Code directory
Hypothalmapath
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 64578-0171_58c8e315-18ee-f679-e063-6294a90a4438
- Product NDC
- 64578-0171
- Form
- LIQUID
- Composition / generic term
- Gelsemium, Ginkgo, Glycyrrhiza, Hydrocotyle, Hypothalamus, Petroselinum, Pituitarum posterium, Pyridoxinum hydrochloricum, Senna, Silicea
- Labeler
- Energetix Corporation
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start / end (source format)
- 20171103
- Source listing expiry
- 20271231
Source-listed ingredients
- GELSEMIUM SEMPERVIRENS ROOT — 12 [hp_X]/59.1mL
- GINKGO — 6 [hp_X]/59.1mL
- LICORICE — 4 [hp_X]/59.1mL
- CENTELLA ASIATICA WHOLE — 4 [hp_X]/59.1mL
- BOS TAURUS HYPOTHALAMUS — 12 [hp_X]/59.1mL
- PETROSELINUM CRISPUM WHOLE — 4 [hp_X]/59.1mL
- SUS SCROFA PITUITARY GLAND, POSTERIOR — 12 [hp_X]/59.1mL
- PYRIDOXINE HYDROCHLORIDE — 12 [hp_X]/59.1mL
- SENNA LEAF — 8 [hp_X]/59.1mL
- SILICON DIOXIDE — 12 [hp_X]/59.1mL
These values do not establish equivalence or a dose recommendation.
Packages
- 59.1 mL in 1 BOTTLE (64578-0171-1) · 64578-0171-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →